Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects
Go back to Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 254.55 -1.27 (0.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $255.82 | 52 Week High | $141.32 | |||
| Open | $254.13 | 52 Week Low | $97.79 | |||
| Day High | $256.73 | P/E | 40.73 | |||
| Day Low | $253.05 | EPS | $6.25 | |||
| Volume | 298,770 | |||||
